Notified Body Liability: TÜV Rheinland Considers Next Move In PIP Scandal Saga

There is a new legal development in the PIP breast implant scandal concerning the liability of German notified body, TÜV Rheinland. But how solid is the most recent ruling?

Gavel

TÜV Rheinland is in “complete disagreement” with a ruling by the Paris Court of Appeal that found the German notified body found partly liable in the PIP breast implant case.

TÜV Rheinland Role

TÜV Rheinland is the notified body that had assessed the conformity of the PIP breast implants' design dossier and PIP's quality system against the EU Medical Device Directive. It did not detect the change in material from medical-grade silicone to a non-medically approved gel, when PIP fraudulently used the cheaper filling for some of its implants. Indeed, Medtech Insighthas learned that PIP used medical-grade silicone to conceal its fraud during each of TÜV Rheinland’s on-site audits. Employees at PIP also mentioned medical-grade silicone in the batch documents on a daily basis, even when they used another type of silicone. The producer is also alleged to have hidden barrels of industrial grade silicone that it was using in instead of medical grade silicone, behind its offices when the notified body visited.

The timing is unfortunate as it pits one of the medtech sector’s notified bodies against a high court just when...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Europe

Global Medtech Guidance Tracker: September 2024

 
• By 

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 40 documents have been posted on the tracker since its last update.

TRiCares Initiates EU Pivotal Study For Topaz Tricuspid Valve Replacement

 

TRiCares announced first implantation of the Topaz transfemoral tricuspid heart valve replacement system as part of the company’s EU pivotal study. If all goes to plan, the device will compete with Edwards’ Evoque system. The announcement follows the company’s $50m series D funding raise in July.

J&J MedTech Keeps Up Cardiovascular Momentum With Shockwave E8 Launch In US

Tim Schmid, executive VP and worldwide chairman of J&J MedTech, expects Shockwave, acquired in April, and Abiomed, purchased in late 2022, to be “long-term gems” for the company. Cardiovascular is among higher-growth segments where J&J has concentrated investments in recent years, along with robotic surgical systems.

Pilot To Program: FDA Issues Accreditation Scheme For Conformity Assessment Draft Guidances

 

The US FDA has published a trio of draft guidance documents for its Assessment Scheme for Conformity Program, which began as a pilot in September 2020 to capitalize on the role of standards in the regulation of medical devices.

More from Geography

Pilot To Program: FDA Issues Accreditation Scheme For Conformity Assessment Draft Guidances

 

The US FDA has published a trio of draft guidance documents for its Assessment Scheme for Conformity Program, which began as a pilot in September 2020 to capitalize on the role of standards in the regulation of medical devices.

Biocomposites Fully Acquires SYNICEM And Subiton Lines, Launches NanoBone In UK

 

UK-based Biocomposites will begin selling in the UK its next-generation osteoinductive bone graft substitute, NanoBone, which came with its acquisition of Artoss GmbH in June 2023. Meanwhile, the company has purchased remaining shares in the manufacturers of SYNICEM and Subiton antibiotic bone cements and preformed antibiotic-loaded spacers.

Senseonics Readies For US Launch Of 'World’s First One-Year CGM'

 

US FDA has greenlighted Senseonics’ Eversense 365 continuous glucose monitor, which must be replaced just once a year. Capable of being integrated with compatible insulin pumps as part of an automated insulin delivery system, the fully implantable device lasts 185 days longer than the Eversense E3 sensor and far outstrips competing CGMs, which last only for 10-14 days.